CASI PHARMACEUTICALS, INC. Capital Expenditures Incurred but Not yet Paid
CASI PHARMACEUTICALS, INC. (CASIF) reported Capital Expenditures Incurred but Not yet Paid of $8.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-05-15
| Period end | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|
| 2024-12-31 | $8.00K 20-F · filed 2026-05-15 |
| 2023-12-31 | $99.00K 20-F · filed 2026-05-15 |
| 2022-12-31 | $44.00K 20-F · filed 2025-03-31 |
| 2021-12-31 | $3.29M 20-F · filed 2024-03-28 |
| 2020-12-31 | $467.00K 20-F · filed 2023-04-26 |